Immunomodulatory effects mediated by serotonin

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Arreola, Rodrigo ^a   Becerril Villanueva, Enrique ^a   Cruz Fuentes, Carlos ^a   Velasco Velázquez, Marco Antonio ^b   Garces Alvarez, Maria Eugenia ^a   Hurtado Alvarado, Gabriela ^c   Quintero Fabian, Saray ^b   Pavon, Lenin ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN TRANSPORTER; CATION TRANSPORT PROTEIN; SEROTONIN RECEPTOR;

ALLERGY; ALZHEIMER DISEASE; APOPTOSIS; ASTHMA; B LYMPHOCYTE; BASOPHIL; BIOSYNTHESIS; CATABOLISM; CELL PROLIFERATION; CHEMOTAXIS; CYTOKINE RELEASE; DENDRITIC CELL; EOSINOPHIL; EXOCYTOSIS; FIBROMYALGIA; HISTORY OF MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFECTION; LEUKOCYTE ACTIVATION; MACROPHAGE; MAJOR DEPRESSION; MALIGNANT NEOPLASTIC DISEASE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; STORAGE; T LYMPHOCYTE; THROMBOCYTE; ANIMAL; ARTHRITIS; GENETICS; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MOUSE; NEOPLASM; NEUTROPHIL CHEMOTAXIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS; ASTHMA; CATION TRANSPORT PROTEINS; CHEMOTAXIS, LEUKOCYTE; HUMANS; IMMUNOMODULATION; LEUKOCYTES; MICE; NEOPLASMS; PROTEIN TRANSPORT; RECEPTORS, SEROTONIN; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84929380005     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/354957     Document Type: Review

References (254)

1. J. Steiner, M. Walter, T. Gos et al., "Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immunemodulated glutamatergic neurotransmission" Journal of Neuroinflammation, vol. 8, article 94, 2011.
2. M. Idzko, E. Panther, C. Stratz et al., "The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release, " Journal of Immunology, vol. 172, no. 10, pp. 6011-6019, 2004.
3. A. Sikander, S. V. Rana, and K. K. Prasad, "Role of serotonin in gastrointestinal motility and irritable bowel syndrome, " Clinica Chimica Acta, vol. 403, no. 1-2, pp. 47-55, 2009.
4. D. L. Murphy, A. M. Andrews, C. H. Wichems, Q. Li, M. Tohda, and B. Greenberg, "Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs, " Journal of Clinical Psychiatry, vol. 59, no. 15, pp. 4-12, 1998.
5. T. Pronina, M. V. Ugrumov, E. Adamskaya et al., "Influence of serotonin on the development and migration of gonadotropinreleasing hormone neurones in rat foetuses, " Journal of Neuroendocrinology, vol. 15, no. 6, pp. 549-558, 2003.
6. M. Kinoshita, K. Ono, T. Horie et al., "Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2R and 5-HT2R and involvement of microRNA-448-mediated repression of KLF5, "Molecular Endocrinology, vol. 24, no. 10, pp. 1978-1987, 2010.
7. M. Knigshoff, R. Dumitrascu, S. Udalov et al., "Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention, " Thorax, vol. 65, no. 11, pp. 949-955, 2010.
8. M. D. Gershon, A. B. Drakontides, and L. L. Ross, "Serotonin: synthesis and release from the myenteric plexus of the mouse intestine, " Science, vol. 149, no. 3680, pp. 197-199, 1965.
9. M. D. Gershon and J. Tack, "The serotonin signaling system: from basic understanding to drug development for functional GI disorders, " Gastroenterology, vol. 132, no. 1, pp. 397-414, 2007.
10. I. Cloz-Tayarani, A.-F. Petit-Bertron, H. D. Venters, and J.-M. Cavaillon, "Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors, " International Immunology, vol. 15, no. 2, pp. 233-240, 2003.
11. R. Mssner and K.-P. Lesch, "Role of serotonin in the immune system and in neuroimmune interactions, " Brain, Behavior, and Immunity, vol. 12, no. 4, pp. 249-271, 1998.
12. T. C. Janeway, H. B. Richardson, and E. A. Park, "Experiments on the vasoconstrictor action of blood serum, " Archives of Internal Medicine, vol. 21, no. 5, pp. 565-603, 1918.
13. M. Vialli and V. Erspamer, "Ricerche sul secreto delle cellule enterocromaffini. IX Intorno alla natura chimica della sostanza specifica, " Bollettino della Societa Medico-Chirurgica di Pavia, vol. 51, pp. 1111-1116, 1937.
14. M. M. Rapport, A. A. Green, and I. H. Page, "Partial purification of the vasoconstrictor in beef serum, " The Journal of Biological Chemistry, vol. 174, no. 2, pp. 735-741, 1948.
15. M. M. Rapport, A. A. Green, and I. H. Page, "Serum vasoconstrictor, serotonin; isolation and characterization, " The Journal of Biological Chemistry, vol. 176, no. 3, pp. 1243-1251, 1948.
16. M. M. Rapport, A. A. Green, and I. H. Page, "Crystalline serotonin, " Science, vol. 108, no. 2804, pp. 329-330, 1948.
17. M. M. Rapport, "Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle, "The Journal of Biological Chemistry, vol. 180, no. 3, pp. 961-969, 1949.
18. K. E. Hamlin and F. E. Fischer, "The synthesis of 5-hydroxytryptamine, " Journal ofThe American Chemical Society, vol. 73, no. 10, pp. 5007-5008, 1951.
19. G. Reid and M. Rand, "Pharmacological actions of synthetic 5-hydroxytryptamine (serotonin, thrombocytin), " Nature, vol. 169, no. 4306, pp. 801-802, 1952.
20. V. Erspamer and B. Asero, "Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine, " Nature, vol. 169, no. 4306, pp. 800-801, 1952.
21. B. M. Twarog and I. H. Page, "Serotonin content of some mammalian tissues and urine and a method for its determination, " The American Journal of Physiology, vol. 175, no. 1, pp. 157-161, 1953.
22. W. G. Dewhurst, "Amines and abnormal mood, " Proceedings of the Royal Society of Medicine, vol. 62, no. 11, pp. 1102-1107, 1969.
23. T. Canli and K.-P. Lesch, "Long story short: the serotonin transporter in emotion regulation and social cognition, " Nature Neuroscience, vol. 10, no. 9, pp. 1103-1109, 2007.
24. L. Passamonti, M. J. Crockett, A. M. Apergis-Schoute et al., "Effects of acute tryptophan depletion on prefrontal-amygdala connectivity while viewing facial signals of aggression, " Biological Psychiatry, vol. 71, no. 1, pp. 36-43, 2012.
25. J. M. Monti, "Serotonin control of sleep-wake behavior, " Sleep Medicine Reviews, vol. 15, no. 4, pp. 269-281, 2011.
26. J. E. Blundell, "Serotonin and appetite, " Neuropharmacology, vol. 23, no. 12, pp. 1537-1551, 1984.
27. L. Bardin, "The complex role of serotonin and 5-HT receptors in chronic pain, " Behavioural Pharmacology, vol. 22, no. 5-6, pp. 390-404, 2011.
28. P. Ducy, "5-HT and bone biology, " Current Opinion in Pharmacology, vol. 11, no. 1, pp. 34-38, 2011.
29. G. Karsenty and V. K. Yadav, "Regulation of bone mass by serotonin: molecular biology and therapeutic implications, " Annual Review of Medicine, vol. 62, pp. 323-331, 2011.
30. N. Li, N. H. Walln, M. Ladjevardi, and P. Hjemdahl, "Effects of serotonin on platelet activation in whole blood, " Blood Coagulation and Fibrinolysis, vol. 8, no. 8, pp. 517-523, 1997.
31. M. Lesurtel, C. Soll, R. Graf, and P.-A. Clavien, "Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives, " Cellular and Molecular Life Sciences, vol. 65, no. 6, pp. 940-952, 2008.
32. M. R. Irwin and A. H. Miller, "Depressive disorders and immunity: 20 years of progress and discovery, " Brain, Behavior, and Immunity, vol. 21, no. 4, pp. 374-383, 2007.
33. M. Masana, N. Santana, F. Artigas, andA. Bortolozzi, "Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review, " Current Topics inMedicinal Chemistry, vol. 12, no. 21, pp. 2357-2374, 2012.
34. S. Tanahashi, S. Yamamura, M. Nakagawa, E. Motomura, and M. Okada, "Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical andmesoaccumbens transmission, " Neuropharmacology, vol. 62, no. 2, pp. 765-774, 2012.
35. M. Abdouh, J. M. Storring, M. Riad et al., "Transcriptional mechanisms for induction of 5-HT1 receptor mRNA and protein in activated B and T lymphocytes, " The Journal of Biological Chemistry, vol. 276, no. 6, pp. 4382-4388, 2001.
36. M. Abdouh, P. R. Albert, E. Drobetsky, J. G. Filep, and E. Kouassi, "5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus, " Brain, Behavior, and Immunity, vol. 18, no. 1, pp. 24-34, 2004.
37. T. M. Aune, H. W. Golden, and K. M. McGrath, "Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo, " Journal of Immunology, vol. 153, no. 2, pp. 489-498, 1994.
38. N. M. Kushnir-Sukhov, A. M. Gilfillan, J. W. Coleman et al., "5-hydroxytryptamine induces mast cell adhesion and migration, " The Journal of Immunology, vol. 177, no. 9, pp. 6422-6432, 2006.
39. B. N. Kang, S. G. Ha, N. S. Bahaie et al., "Regulation of serotonin-induced trafficking and migration of eosinophils, " PLoS ONE, vol. 8, no. 1, Article ID e54840, 2013.
40. M. Len-Ponte, G. P. Ahern, and P. J. O'Connell, "Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor, " Blood, vol. 109, no. 8, pp. 3139-3146, 2007.
41. K. Iken, S. Chheng, A. Fargin, A.-C. Goulet, and E. Kouassi, "Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors, " Cellular Immunology, vol. 163, no. 1, pp. 1-9, 1995.
42. T. Drk, E. Panther, T. Mller et al., "5-hydroxytryptamine modulates cytokine and chemokine production in LPS-primed humanmonocytes via stimulation of different 5-HTR subtypes, " International Immunology, vol. 17, no. 5, pp. 599-606, 2005.
43. T. Mller, T. Drk, B. Blumenthal et al., "5-hydroxytryptamine modulates migration, cytokine and chemokine release and Tcell priming capacity of dendritic cells in vitro and in vivo, " PLoS ONE, vol. 4, no. 7, Article ID e6453, 2009.
44. T. Rivera-Baltanas, J. M. Olivares, J. R. Martinez-Villamarin, E. Y. Fenton, L. E. Kalynchuk, andH. J. Caruncho, "Serotonin 2A receptor clustering in peripheral lymphocytes is altered inmajor depression and may be a biomarker of therapeutic efficacy, " Journal of Affective Disorders, vol. 163, pp. 47-55, 2014.
45. S. A. Boehme, F. M. Lio, L. Sikora et al., "Cutting edge: Serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin, " Journal of Immunology, vol. 173, no. 6, pp. 3599-3603, 2004.
46. E. Magrini, I. Szabò, A. Doni, J. Cibella, and A. Viola, "Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12, " PLoS ONE, vol. 6, no. 8, Article ID e22482, 2011.
47. B. L. Fiebich, R. S. Akundi, M. Seidel et al., "Expression of 5-HT3A receptors in cells of the immune system, " Scandinavian Journal of Rheumatology, vol. 33, supplement 119, pp. 9-11, 2004.
48. A. Rinaldi, A. M. Chiaravalli, M. Mian et al., "Serotonin receptor 3A expression in normal and neoplastic B cells, " Pathobiology, vol. 77, no. 3, pp. 129-135, 2010.
49. J. D. Holbrook, C. H. Gill, N. Zebda et al., "Characterisation of 5-HT3, 5-HT3 and 5-HT3 receptor subunits: evolution, distribution and function, " Journal of Neurochemistry, vol. 108, no. 2, pp. 384-396, 2009.
50. N. Katoh, F. Soga, T. Nara et al., "Effect of serotonin on the differentiation of human monocytes into dendritic cells, " Clinical and Experimental Immunology, vol. 146, no. 2, pp. 354-361, 2006.
51. B. A. Faraj, Z. L. Olkowski, and R. T. Jackson, "Expression of a high-affinity serotonin transporter in human lymphocytes, " International Journal of Immunopharmacology, vol. 16, no. 7, pp. 561-567, 1994.
52. L. Lima and M. Urbina, "Serotonin transporter modulation in blood lymphocytes from patients with major depression, " Cellular and Molecular Neurobiology, vol. 22, no. 5-6, pp. 797-804, 2002.
53. F. Fazzino, M. Urbina, N. Cedeno, and L. Lima, "Fluoxetine treatment to rats modifies serotonin transporter and cAMP in lymphocytes, CD4+ and CD8+ subpopulations and interleukins 2 and 4, " International Immunopharmacology, vol. 9, no. 4, pp. 463-467, 2009.
54. T. Rivera-Baltanas, J. M. Olivares, M. Calado-Otero, L. E. Kalynchuk, J. R. Martinez-Villamarin, and H. J. Caruncho, "Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder, " Journal of Affective Disorders, vol. 137, no. 1-3, pp. 46-55, 2012.
55. M. Medina-Martel, M. Urbina, F. Fazzino, and L. Lima, "Serotonin transporter in lymphocytes of rats exposed to physical restraint stress, " NeuroImmunoModulation, vol. 20, no. 6, pp. 361-367, 2013.
56. J.-I. Iga, S.-I. Ueno, K. Yamauchi et al., "Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine, " Neuroscience Letters, vol. 389, no. 1, pp. 12-16, 2005.
57. T. Benton, K. Lynch, B. Dub et al., "Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication, " Psychosomatic Medicine, vol. 72, no. 9, pp. 925-932, 2010.
58. P. J. O'Connell, X. Wang, M. Leon-Ponte, C. Griffiths, S. C. Pingle, and G. P. Ahern, "A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells, " Blood, vol. 107, no. 3, pp. 1010-1017, 2006.
59. K. Thorslund, B. Amatya, A. E. Dufva, and K. Nordlind, "The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress, " Archives of Dermatological Research, vol. 305, no. 2, pp. 99-104, 2013.
60. M. H. Andersen, "The specific targeting of immune regulation: T-cell responses against Indoleamine 2, 3-dioxygenase, " Cancer Immunology, Immunotherapy, vol. 61, no. 8, pp. 1289-1297, 2012.
61. G. Furset, Y. Flsand, and M. Sioud, "Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands, " Immunology, vol. 123, no. 2, pp. 263-271, 2008.
62. P. Chaitidis, E. E. Billett, V. B. O'Donnell et al., "Th2 response of human peripheral monocytes involves isoform-specific induction ofmonoamine oxidase-A, " Journal of Immunology, vol. 173, no. 8, pp. 4821-4827, 2004.
63. R. Mssner, O. Mikova, E. Koutsilieri et al., "Consensus paper of theWFSBP task force on biological markers: biological markers in depression, "World Journal of Biological Psychiatry, vol. 8, no. 3, pp. 141-174, 2007.
64. F. Fazzino, C. Montes, M. Urbina, I. Carreira, and L. Lima, "Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation, " Journal of Neuroimmunology, vol. 196, no. 1-2, pp. 173-180, 2008.
65. S. Pena, E. Baccichet, M. Urbina, I. Carreira, and L. Lima, "Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients, " International Immunopharmacology, vol. 5, no. 6, pp. 1069-1076, 2005.
66. L. Bazzichi, G. Giannaccini, L. Betti et al., "Alteration of serotonin transporter density and activity in fibromyalgia, " Arthritis Research & Therapy, vol. 8, article R99, 2006.
67. J. Williams, P. McGuffin, M. Nothen, and M. J. Owen, "Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia, " The Lancet, vol. 349, no. 9060, article 1221, 1997.
68. H. M. Abdolmaleky, S. V. Faraone, S. J. Glatt, and M. T. Tsuang, "Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia, " Schizophrenia Research, vol. 67, no. 1, pp. 53-62, 2004.
69. G. R. Shariati, G. Ahangari, A. Hossein-nezhad, S. M. Asadi, F. Pooyafard, and H. R. Ahmadkhaniha, "Expression changes of serotonin receptor gene subtype 5HT3a in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and olanzapin, " Iranian Journal of Allergy, Asthma and Immunology, vol. 8, no. 3, pp. 135-139, 2009.
70. D. Marazziti, B. Dell'Osso, S. Baroni et al., "Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients, " Pharmacopsychiatry, vol. 39, no. 1, pp. 35-38, 2006.
71. F. Lechin, B. van der Dijs, B. Orozco et al., "The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: a double-blind, crossover, placebo-controlled study, " Journal of Clinical Pharmacology, vol. 38, no. 10, pp. 918-925, 1998.
72. L. C. A. Martins, N. P. Rocha, K. C. L. Torres et al., "Diseasespecific expression of the serotonin-receptor 5-HT2 in natural killer cells in Alzheimer's dementia, " Journal of Neuroimmunology, vol. 251, no. 1-2, pp. 73-79, 2012.
73. D. K. Babu, A. Diaz, T. Samikkannu et al., "Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation, "Alcoholism:Clinical and Experimental Research, vol. 33, no. 10, pp. 1731-1738, 2009.
74. M. F. Seidel, B. L. Fiebich, G. Ulrich-Merzenich, E. Candelario-Jalil, F.-W. Koch, and H. Vetter, "Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells, " Rheumatology International, vol. 28, no. 10, pp. 1017-1022, 2008.
75. M. Urbina, R. Arroyo, and L. Lima, "5-HT7 receptors and tryptophan hydroxylase in lymphocytes of rats: mitogen activation, physical restraint or treatmentwith reserpine, " Neuroimmunomodulation, vol. 21, no. 5, pp. 240-249, 2014.
76. D. L. Evans, K. G. Lynch, T. Benton et al., "Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome, " Biological Psychiatry, vol. 63, no. 9, pp. 899-905, 2008.
77. M. Schaefer, R. Sarkar, V. Knop et al., "Escitalopram for the prevention of peginterferon-2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial, " Annals of Internal Medicine, vol. 157, no. 2, pp. 94-103, 2012.
78. W. Mller and T. Stratz, "Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonis tropisetron, " Scandinavian Journal of Rheumatology, vol. 33, no. s119, pp. 44-48, 2004.
79. P. Palit and N. Ali, "Oral therapy with sertraline, a selective serotonin reuptake inhibitor, shows activity against Leishmania donovani, " Journal of Antimicrobial Chemotherapy, vol. 61, no. 5, pp. 1120-1124, 2008.
80. C.-K. Fang, H.-W. Chen, I.-T. Chiang et al., "Mirtazapine inhibits tumor growth via immune response and serotonergic system, " PLoS ONE, vol. 7, no. 7, Article ID e38886, 2012.
81. D. E. Nichols and C. D. Nichols, "Serotonin receptors, " Chemical Reviews, vol. 108, no. 5, pp. 1614-1641, 2008.
82. R. Schwarcz, J. P. Bruno, P. J. Muchowski, and H.-Q. Wu, "Kynurenines in the mammalian brain: when physiology meets pathology, " Nature Reviews Neuroscience, vol. 13, no. 7, pp. 465-477, 2012.
83. S. O. Silva, M. R. Rodrigues, S. R. Q. Carvalho, L. H. Catalani, A. Campa, and V. F. Ximenes, "Oxidation of melatonin and its catabolites, N1-acetyl-N 2-formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes, " Journal of Pineal Research, vol. 37, no. 3, pp. 171-175, 2004.
84. T. W. Stone and L. G. Darlington, "Endogenous kynurenines as targets for drug discovery and development, " Nature Reviews Drug Discovery, vol. 1, no. 8, pp. 609-620, 2002.
85. L. Vcsei, L. Szalrdy, F. Flp, and J. Toldi, "Kynurenines in the CNS: recent advances and new questions, " Nature Reviews Drug Discovery, vol. 12, no. 1, pp. 64-82, 2013.
86. A. Carrillo-Vico, P. J. Lardone, N. Alvarez-nchez, A. Rodrguez-Rodrguez, and J. M. Guerrero, "Melatonin: buffering the immune system, " International Journal of Molecular Sciences, vol. 14, no. 4, pp. 8638-8683, 2013.
87. D. J. Walther and M. Bader, "A unique central tryptophan hydroxylase isoform, " Biochemical Pharmacology, vol. 66, no. 9, pp. 1673-1680, 2003.
88. D. J. Walther, J.-U. Peter, S. Bashammakh et al., "Synthesis of serotonin by a second tryptophan hydroxylase isoform, " Science, vol. 299, no. 5603, p. 76, 2003.
89. S. A. Sakowski, T. J. Geddes, D. M. Thomas, E. Levi, J. S. Hatfield, and D. M. Kuhn, "Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies, " Brain Research, vol. 1085, no. 1, pp. 11-18, 2006.
90. D.-Y. Kim and M. Camilleri, "Serotonin: a mediator of the brain-gut connection, " The American Journal of Gastroenterology, vol. 95, no. 10, pp. 2698-2709, 2000.
91. M. C. Boadle-Biber, "Regulation of serotonin synthesis, " Progress in Biophysics and Molecular Biology, vol. 60, no. 1, pp. 1-15, 1993.
92. G. M. Tyce, "Origin and metabolism of serotonin, " Journal of Cardiovascular Pharmacology, vol. 16, supplement 3, pp. S1-S7, 1990.
93. D. Acuna-Castroviejo, G. Escames, C. Venegas et al., "Extrapineal melatonin: sources, regulation, and potential functions, " Cellular and Molecular Life Sciences, vol. 71, no. 16, pp. 2997-3025, 2014.
94. L. M. E. Finocchiaro, V. E. Nahmod, and J. M. Launay, "Melatonin biosynthesis and metabolism in peripheral blood mononuclear leucocytes, " Biochemical Journal, vol. 280, part 3, pp. 727-731, 1991.
95. J. C. Mayo, R. M. Sainz, D.-X. Tan et al., "Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages, " Journal of Neuroimmunology, vol. 165, no. 1-2, pp. 139-149, 2005.
96. R. M. Slominski, R. J. Reiter, N. Schlabritz-Loutsevitch, R. S. Ostrom, and A. T. Slominski, "Melatonin membrane receptors in peripheral tissues: distribution and functions, "Molecular and Cellular Endocrinology, vol. 351, no. 2, pp. 152-166, 2012.
97. R. Lozda and I. Purvin, "Quantification of serotonin Osulphate by LC-MS method in plasma of healthy volunteers, " Frontiers in Pharmacology, vol. 5, article 62, 2014.
98. M. Okuma, T. Tokuyama, S. Senoh, F. Hirata, and O. Hayaishi, "Antagonism of 5-hydroxykynurenamine against serotonin action on platelet aggregation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 2, pp. 643-645, 1976.
99. M. P. Heyes, K. Saito, and S. P. Markey, "Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid, " Biochemical Journal, vol. 283, no. 3, pp. 633-635, 1992.
100. M. P. Heyes, C. L. Achim, C. A. Wiley, E. O. Major, K. Saito, and S. P. Markey, "Human microglia convert l-tryptophan into the neurotoxin quinolinic acid, " Biochemical Journal, vol. 320, part 2, pp. 595-597, 1996.
101. Y. Mndi and L. Vcsei, "The kynurenine system and immunoregulation, " Journal of Neural Transmission, vol. 119, no. 2, pp. 197-209, 2012.
102. H. Xu, G. X. Zhang, B. Ciric, and A. Rostami, "IDO: a doubleedged sword for TH1/TH2 regulation, " Immunology Letters, vol. 121, no. 1, pp. 1-6, 2008.
103. G. Frumento, R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G. B. Ferrara, "Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase, "The Journal of Experimental Medicine, vol. 196, no. 4, pp. 459-468, 2002.
104. L. N. Squires, J. A. Jakubowski, J. N. Stuart et al., "Serotonin catabolism and the formation and fate of 5-hydroxyindole thiazolidine carboxylic acid, "The Journal of Biological Chemistry, vol. 281, no. 19, pp. 13463-13470, 2006.
105. A. J. Harmar, R. A. Hills, E. M. Rosser et al., "IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels, " Nucleic Acids Research, vol. 37, pp. D680-D685, 2009.
106. J. L. Sharman, H. E. Benson, A. J. Pawson et al., "IUPHARDB: updated database content and new features, " Nucleic Acids Research, vol. 41, no. 1, pp. D1083-D1088, 2013.
107. C. M. Villaln and D. Centurin, "Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications, " Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 376, no. 1-2, pp. 45-63, 2007.
108. L. C. Berumen, A. Rodruez, R. Miledi, and G. Garc-Alcocer, "Serotonin receptors in hippocampus, " The Scientific World Journal, vol. 2012, Article ID 823493, 15 pages, 2012.
109. Z. Sun, X. Tang, F. Lin, and S. Chen, "The WD40 repeat protein WDR26 binds G and promotes G-dependent signal transduction and leukocyte migration, " The Journal of Biological Chemistry, vol. 286, no. 51, pp. 43902-43912, 2011.
110. Y. Lin and A. V. Smrcka, "Understandingmolecular recognition by G protein betagamma subunits on the path to pharmacological targeting, " Molecular Pharmacology, vol. 80, no. 4, pp. 551-557, 2011.
111. Z. Xie, S. P. Lee, B. F. O'Dowd, and S. R. George, "Serotonin 5-HT1 and 5-HT1 receptors formhomodimers when expressed alone and heterodimers when co-expressed, " FEBS Letters, vol. 456, no. 1, pp. 63-67, 1999.
112. K. Herrick-Davis, E. Grinde, and J. E. Mazurkiewicz, "Biochemical and biophysical characterization of serotonin 5-HT2 receptor homodimers on the plasma membrane of living cells, " Biochemistry, vol. 43, no. 44, pp. 13963-13971, 2004.
113. K. Herrick-Davis, B. A. Weaver, E. Grinde, and J. E. Mazurkiewicz, "Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: Real-time visualization with confocal fluorescence resonance energy transfer, " The Journal of Biological Chemistry, vol. 281, no. 37, pp. 27109-27116, 2006.
114. K. Herrick-Davis, E. Grinde, T. Lindsley, A. Cowan, and J. E. Mazurkiewicz, "Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogramanalysis: evidence for homodimers without monomers or tetramers, " Journal of Biological Chemistry, vol. 287, no. 28, pp. 23604-23614, 2012.
115. K. Herrick-Davis, E. Grinde, T. J. Harrigan, and J. E. Mazurkiewicz, "Inhibition of serotonin 5-hydroxytryptamine2C receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein, " The Journal of Biological Chemistry, vol. 280, no. 48, pp. 40144-40151, 2005.
116. L. P. Pellissier, G. Barthet, F. Gaven et al., "G protein activation by serotonin type 4 receptor dimers. Evidence that turning on two protomers is more efficient, " The Journal of Biological Chemistry, vol. 286, no. 12, pp. 9985-9997, 2011.
117. G. Milligan, "G protein-coupled receptor dimerisation: molecular basis and relevance to function, " Biochimica et Biophysica Acta-Biomembranes, vol. 1768, no. 4, pp. 825-835, 2007.
118. S. Ganguly, A. H. A. Clayton, and A. Chattopadhyay, "Organization of higher-order oligomers of the serotonin1A receptor explored utilizing homo-FRET in live cells, " Biophysical Journal, vol. 100, no. 2, pp. 361-368, 2011.
119. C. Wang, Y. Jiang, J. Ma et al., "Structural basis for molecular recognition at serotonin receptors, " Science, vol. 340, no. 6132, pp. 610-614, 2013.
120. D. Wacker, C. Wang, V. Katritch et al., "Structural features for functional selectivity at serotonin receptors, " Science, vol. 340, no. 6132, pp. 615-619, 2013.
121. N. P. Barrera, P. Herbert, R. M. Henderson, I. L. Martin, and J. M. Edwardson, "Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12595-12600, 2005.
122. A. A. Jensen, P. A. Davies, H. Bruner-Osborne, and K. Krzywkowski, "3B but which 3B And that's just one of the questions: the heterogeneity of human 5-HT3 receptors, " Trends in Pharmacological Sciences, vol. 29, no. 9, pp. 437-444, 2008.
123. N. M. Barnes, T. G. Hales, S. C. R. Lummis, and J. A. Peters, "The 5-HT3 receptor-the relationship between structure and function, " Neuropharmacology, vol. 56, no. 1, pp. 273-284, 2009.
124. S. M. Sine and A. G. Engel, "Recent advances in Cys-loop receptor structure and function, " Nature, vol. 440, no. 7083, pp. 448-455, 2006.
125. J. A. Peters, T. G. Hales, and J. J. Lambert, "Molecular determinants of single-channel conductance and ion selectivity in the Cys-loop family: insights from the 5-HT3 receptor, " Trends in Pharmacological Sciences, vol. 26, no. 11, pp. 587-594, 2005.
126. H. Sun, X.-Q. Hu, E. M. Moradel, F. F. Weight, and L. Zhang, "Modulation of 5-HT3 receptor-mediated response and trafficking by activation of protein kinase C, " The Journal of Biological Chemistry, vol. 278, no. 36, pp. 34150-34157, 2003.
127. N. Yaakob, D. T. Malone, B. Exintaris, andH. R. Irving, "Heterogeneity amongst 5-HT3 receptor subunits: is this significant" Current Molecular Medicine, vol. 11, no. 1, pp. 57-68, 2011.
128. A. M. Karnovsky, L. F. Gotow, D. D. McKinley et al., "A cluster of novel serotonin receptor 3-like genes on human chromosome 3, " Gene, vol. 319, no. 1-2, pp. 137-148, 2003.
129. B. Niesler, B. Frank, J. Kapeller, and G. A. Rappold, "Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E, " Gene, vol. 310, no. 1-2, pp. 101-111, 2003.
130. D. Belelli, J. M. Balcarek, A. G. Hope, J. A. Peters, J. J. Lambert, and T. P. Blackburn, "Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit, " Molecular Pharmacology, vol. 48, no. 6, pp. 1054-1062, 1995.
131. B. Niesler, J. Walstab, S. Combrink et al., "Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E, " Molecular Pharmacology, vol. 72, no. 1, pp. 8-17, 2007.
132. M. Ohara-Imaizumi, H. Kim, M. Yoshida et al., "Serotonin regulates glucose-stimulated insulin secretion from pancreatic cells during pregnancy, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 48, pp. 19420-19425, 2013.
133. J. A. van Hooft and H. P. M. Vijverberg, "5-HT(3) receptors and neurotransmitter release in the CNS: a nerve ending story" Trends in Neurosciences, vol. 23, no. 12, pp. 605-610, 2000.
134. B. L. Fiebich, R. S. Akundi, K. Lieb et al., "Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharidestimulated primary human monocytes, " Scandinavian Journal of Rheumatology, Supplement, vol. 33, no. 119, pp. 28-32, 2004.
135. C. Stratz, H. S. Bhatia, R. S. Akundi et al., "The anti-inflammatory effects of the 5-HT3 receptor antagonist tropisetron are mediated by the inhibition of p38 MAPK activation in primary human monocytes, " International Immunopharmacology, vol. 13, no. 4, pp. 398-402, 2012.
136. C. P. Mercado and F. Kilic, "Molecular mechanisms of sert in platelets: regulation of plasma serotonin levels, " Molecular Interventions, vol. 10, no. 4, pp. 231-241, 2010.
137. M. A. Margoob and D. Mushtaq, "Serotonin transporter gene polymorphism and psychiatric disorders: Is there a link, " Indian Journal of Psychiatry, vol. 53, no. 4, pp. 289-299, 2011.
138. F. Kilic and G. Rudnick, "Oligomerization of serotonin transporter and its functional consequences, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3106-3111, 2000.
139. A. M. Kocabas, G. Rudnick, and F. Kilic, "Functional consequences of homo-but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters, " Journal of Neurochemistry, vol. 85, no. 6, pp. 1513-1520, 2003.
140. D. Ozaslan, S. Wang, B. A. Ahmed et al., "Glycosyl modification facilitates homo-and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues, " The Journal of Biological Chemistry, vol. 278, no. 45, pp. 43991-44000, 2003.
141. C. P. Mercado, E. Ziu, and F. Kilic, "Communication between 5-HT and small GTPases, " Current Opinion in Pharmacology, vol. 11, no. 1, pp. 23-28, 2011.
142. D. J. Walther, J.-U. Peter, S. Winter et al., "Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release, " Cell, vol. 115, no. 7, pp. 851-862, 2003.
143. N. Paulmann, M. Grohmann, J.-P. Voigt et al., "Intracellular serotonin modulates insulin secretion from pancreatic-cells by protein serotonylation, " PLoS Biology, vol. 7, no. 10, Article ID e1000229, 2009.
144. R. Shirakawa, A. Yoshioka, H. Horiuchi, H. Nishioka, A. Tabuchi, and T. Kita, "Small GTPase Rab4 regulates Ca2+-induced alpha-granule secretion in platelets, " The Journal of Biological Chemistry, vol. 275, no. 43, pp. 33844-33849, 2000.
145. S. M. Schoenwaelder, S. C. Hughan, K. Boniface et al., "RhoA sustains integrin alpha IIbbeta 3 adhesion contacts under high shear, " The Journal of Biological Chemistry, vol. 277, no. 17, pp. 14738-14746, 2002.
146. A. Hall and G. Lalli, "Rho and Ras GTPases in axon growth, guidance, and branching, " Cold Spring Harbor Perspectives in Biology, vol. 2, no. 2, Article ID a001818, 2010.
147. O. Visvikis, M. P. Maddugoda, and E. Lemichez, "Direct modifications of Rho proteins: deconstructing GTPase regulation, " Biology of the Cell, vol. 102, no. 7, pp. 377-389, 2010.
148. C. Guilluy, M. Rolli-Derkinderen, P.-L. Tharaux, G. Melino, P. Pacaud, and G. Loirand, "Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells, "The Journal of Biological Chemistry, vol. 282, no. 5, pp. 2918-2928, 2007.
149. K. Vikenes, M. Farstad, and J. E. Nordrehaug, "Serotonin is associated with coronary artery disease and cardiac events, " Circulation, vol. 100, no. 5, pp. 483-489, 1999.
150. Y. Liu, L. Wei, D. L. Laskin, and B. L. Fanburg, "Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells, " American Journal of Respiratory Cell andMolecular Biology, vol. 44, no. 4, pp. 548-555, 2011.
151. M. Ostrowski, N. B. Carmo, S. Krumeich et al., "Rab27a and Rab27b control different steps of the exosome secretion pathway, " Nature Cell Biology, vol. 12, no. 1, pp. 19-30, 2010.
152. E. K. Novak, R. Gautam, M. Reddington et al., "The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granule-specific and dependent on genetic background, " Blood, vol. 100, no. 1, pp. 128-135, 2002.
153. T. Tolmachova, M. Abrink, C. E. Futter, K. S. Authi, and M. C. Seabra, "Rab27b regulates number and secretion of platelet dense granules, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 14, pp. 5872-5877, 2007.
154. Z. Yi, H. Yokota, S. Torii et al., "The Rab27a/granuphilin complex regulates the exocytosis of insulin-containing densecore granules, "Molecular and Cellular Biology, vol. 22, no. 6, pp. 1858-1867, 2002.
155. A. Imai, S. Yoshie, T. Nashida, H. Shimomura, and M. Fukuda, "The small GTPase Rab27B regulates amylase release from rat parotid acinar cells, " Journal of Cell Science, vol. 117, no. 10, pp. 1945-1953, 2004.
156. B. A. Ahmed, I. A. Bukhari, B. C. Jeffus et al., "The cellular distribution of serotonin transporter is impeded on serotoninaltered vimentin network, " PLoS ONE, vol. 4, no. 3, Article ID e4730, 2009.
157. B. A. Ahmed, B. C. Jeffus, S. I. A. Bukhari et al., "Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter, "The Journal of Biological Chemistry, vol. 283, no. 14, pp. 9388-9398, 2008.
158. E. K. Haddad, X. Wu, J. A. Hammer III, and P. A. Henkart, "Defective granule exocytosis in Rab27a-deficient lymphocytes fromAshen mice, " The Journal of Cell Biology, vol. 152, no. 4, pp. 835-842, 2001.
159. J. C. Stinchcombe and G. M. Griffiths, "Normal and abnormal secretion by haemopoietic cells, " Immunology, vol. 103, no. 1, pp. 10-16, 2001.
160. M. Angel, del Pozo, M. Vicente-Manzanares, R. Tejedor, J. M. Serrador, and F. Snchez-Madrid, "Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes, " European Journal of Immunology, vol. 29, no. 11, pp. 3609-3620, 1999.
161. A. Bellizzi, A. Mangia, A. Chiriatti et al., "RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease, " International Journal of Molecular Medicine, vol. 22, no. 1, pp. 25-31, 2008.
162. M. J. Brown, J. A. Hallam, E. Colucci-Guyon, and S. Shaw, "Rigidity of circulating lymphocytes is primarily conferred by vimentin intermediate filaments, " The Journal of Immunology, vol. 166, no. 11, pp. 6640-6646, 2001.
163. G. P. Ahern, "5-HT and the immune system, " Current Opinion in Pharmacology, vol. 11, no. 1, pp. 29-33, 2011.
164. B. S. Beikmann, I. D. Tomlinson, S. J. Rosenthal, and A. M. Andrews, "Serotonin uptake is largely mediated by platelets versus lymphocytes in peripheral blood cells, " ACS Chemical Neuroscience, vol. 4, no. 1, pp. 161-170, 2013.
165. S. W. Watts, J. R. C. Priestley, and J. M. Thompson, "Serotonylation of vascular proteins important to contraction, " PLoS ONE, vol. 4, no. 5, Article ID e5682, 2009.
166. F. Hayashi, T. K. Means, and A. D. Luster, "Toll-like receptors stimulate human neutrophil function, " Blood, vol. 102, no. 7, pp. 2660-2669, 2003.
167. D. Duerschmied, G. L. Suidan, M. Demers et al., "Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice, " Blood, vol. 121, no. 6, pp. 1008-1015, 2013.
168. N. Herr, M. Mauler, T. Witsch et al., "Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice, " PLoS ONE, vol. 9, no. 2, Article ID e88316, 2014.
169. B. Passlick, D. Flieger, andH. W. L. Ziegler-Heitbrock, "Identification and characterization of a novel monocyte subpopulation in human peripheral blood, " Blood, vol. 74, no. 7, pp. 2527-2534, 1989.
170. N. V. Serbina, T. Jia, T. M. Hohl, and E. G. Pamer, "Monocytemediated defense against microbial pathogens, " Annual Review of Immunology, vol. 26, pp. 421-452, 2008.
171. A. A. Tokmakov, M. P. Kykhova, O. V. Koshkina, and V. I. Vasil'ev, "The effect of serotonin on the functional activity of monocytes, " Tsitologiya, vol. 33, no. 1, pp. 81-87, 1991.
172. D. H. S. Silverman, H. Wu, and M. L. Karnovsky, "Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release, " Biochemical and Biophysical Research Communications, vol. 131, no. 3, pp. 1160-1167, 1985.
173. H. Nomura, E. Sato, S. Koyama et al., "Histamine stimulates alveolar macrophages to release neutrophil and monocyte chemotactic activity, " Journal of Laboratory and Clinical Medicine, vol. 138, no. 4, pp. 226-235, 2001.
174. Z. Mikulski, Z. Zasona, L. Cakarova et al., "Serotonin activates murine alveolar macrophages through 5-HT2C receptors, " The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 299, no. 2, pp. L272-L280, 2010.
175. M. Freire-Garabal, M. J. Nnez, J. Balboa et al., "Serotonin upregulates the activity of phagocytosis through 5-HT1 receptors, " British Journal of Pharmacology, vol. 139, no. 2, pp. 457-463, 2003.
176. E. M. Sternberg, J. Trial, and C. W. Parker, "Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists, " The Journal of Immunology, vol. 137, no. 1, pp. 276-282, 1986.
177. G. Mnard, V. Turmel, and E. Y. Bissonnette, "Serotonin modulates the cytokine network in the lung: Involvement of prostaglandin E2, " Clinical and Experimental Immunology, vol. 150, no. 2, pp. 340-348, 2007.
178. J. J. Mandoki, N. Mendoza-Patino, J. A. Molina-Guarneros, F. A. Jimnez-Orozco, M. A. Velasco-Velzquez, and M. J. Garc-Mondragn, "Hormone multifunctionalities: a theory of endocrine signaling, command and control, " Progress in Biophysics and Molecular Biology, vol. 86, no. 3, pp. 353-377, 2004.
179. J. C. Jackson, R. F. Walker, W. H. Brooks, and T. L. Roszman, "Specific uptake of serotonin by murine macrophages, " Life Sciences, vol. 42, no. 17, pp. 1641-1650, 1988.
180. W. E. Paul, Fundamental Immunology, Lippincott Williams & Wilkins, Wolters Kluwer, 7th edition, 2012.
181. M. Merad, P. Sathe, J. Helft, J. Miller, and A. Mortha, "The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting, " Annual Review of Immunology, vol. 31, pp. 563-604, 2013.
182. M. Merad andM. G. Manz, "Dendritic cell homeostasis, " Blood, vol. 113, no. 15, pp. 3418-3427, 2009.
183. S.-F. Hsu, P. J. O'Connell, V. A. Klyachko et al., "Fundamental Ca2+ signaling mechanisms in mouse dendritic cells: CRAC is themajor Ca2+ entry pathway, " The Journal of Immunology, vol. 166, no. 10, pp. 6126-6133, 2001.
184. J. A. Roake, "Pathways of dendritic cell differentiation and development, " Eye, vol. 9, no. 2, pp. 161-166, 1995.
185. N. Li, J. E. Ghia, H. Wang et al., "Serotonin activates dendritic cell function in the context of gut inflammation, " The American Journal of Pathology, vol. 178, no. 2, pp. 662-671, 2011.
186. M. Montes, D. McIlroy, A. Hosmalin, and A. Trautmann, "Calcium responses elicited in human T cells and dendritic cells by cell-cell interaction and soluble ligands, " International Immunology, vol. 11, no. 4, pp. 561-568, 1999.
187. N. A. Khan, J. P. Meyniel, and P. Deschaux, "Ca2+/calmodulin and protein kinase C regulation of serotonin transport in human K562 lymphocytes, " Cellular Immunology, vol. 172, no. 2, pp. 269-274, 1996.
188. D. O. Slauson, C. Walker, F. Kristensen, Y. Wang, and A. L. de Weck, "Mechanisms of serotonin-induced lymphocyte proliferation inhibition, " Cellular Immunology, vol. 84, no. 2, pp. 240-252, 1984.
189. I. A. Khan, G. Bhardwaj, N. Malla, C. Wattal, and S. C. Agarwal, "Effect of serotonin on T lymphocyte proliferation in vitro in healthy individuals, " International Archives of Allergy and Applied Immunology, vol. 81, no. 4, pp. 378-380, 1986.
190. M. R. I. Young, J. L. Kut, M. P. Coogan, M. A. Wright, M. E. Young, and J. Matthews, "Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin, " Immunology, vol. 80, no. 3, pp. 395-400, 1993.
191. M. R. I. Young and J. P. Matthews, "Serotonin regulation of T-cell subpopulations and of macrophage accessory function, " Immunology, vol. 84, no. 1, pp. 148-152, 1995.
192. N. Cedeno, M. Urbina, F. Obregn, and L. Lima, "Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens, " Journal of Neuroimmunology, vol. 159, no. 1-2, pp. 31-40, 2005.
193. M. Urbina, S. Pineda, L. Pinango, I. Carreira, and L. Lima, " [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine, " International Journal of Immunopharmacology, vol. 21, no. 10, pp. 631-646, 1999.
194. T. Kurosaki, "B-lymphocyte biology, " Immunological Reviews, vol. 237, no. 1, pp. 5-9, 2010.
195. E. J. Meredith, M. J. Holder, A. Chamba et al., "The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics, " The FASEB Journal, vol. 19, no. 9, pp. 1187-1189, 2005.
196. R. M. Welsh, M. Y. Lin, B. L. Lohman, S. M. Varga, C. C. Zarozinski, and L. K. Selin, "Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections, " Immunological Reviews, vol. 159, pp. 79-93, 1997.
197. E. Vivier, D. H. Raulet, A. Moretta et al., "Innate or adaptive immunityThe example of natural killer cells, " Science, vol. 331, no. 6013, pp. 44-49, 2011.
198. A. Betten, C. Dahlgren, S. Hermodsson, and K. Hellstrand, "Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis, " Journal of Leukocyte Biology, vol. 70, no. 1, pp. 65-72, 2001.
199. K. Hellstrand and S. Hermodsson, "Monocyte-mediated suppression of IL-2-induced NK-cell activation. Regulation by 5-HT(1A)-type serotonin receptors, " Scandinavian Journal of Immunology, vol. 32, no. 2, pp. 183-192, 1990.
200. K. Hellstrand and S. Hermodsson, "Enhancement of human natural killer cell cytotoxicity by serotonin: Role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors, " Cellular Immunology, vol. 127, no. 1, pp. 199-214, 1990.
201. K. Hellstrand, C. Czerkinsky, A. Ricksten et al., "Role of serotonin in the regulation of interferon-production by human natural killer cells, " Journal of Interferon Research, vol. 13, no. 1, pp. 33-38, 1993.
202. M. G. Frank, D. R. Johnson, S. E. Hendricks, and J. L. Wieseler Frank, "Monocyte 5-HT1 receptors mediate pindobind suppression of natural killer cell activity: modulation by catalase, " International Immunopharmacology, vol. 1, no. 2, pp. 247-253, 2001.
203. C. L. Sokol, G. M. Barton, A. G. Farr, and R. Medzhitov, "A mechanism for the initiation of allergen-induced T helper type 2 responses, "Nature Immunology, vol. 9, no. 3, pp. 310-318, 2008.
204. E. Schneider, F. MacHavoine, R. Bricard-Rignault et al., "Downregulation of basophil-derived IL-4 and in vivo T2 IgE responses by serotonin and other organic cation transporter 3 ligands, " Journal of Allergy and Clinical Immunology, vol. 128, no. 4, pp. 864. e2-871. e2, 2011.
205. C. L. Sokol and R. Medzhitov, "Emerging functions of basophils in protective and allergic immune responses, " Mucosal Immunology, vol. 3, no. 2, pp. 129-137, 2010.
206. N. van Panhuys, M. Prout, E. Forbes, B. Min, W. E. Paul, and G. le Gros, "Basophils are the major producers of IL-4 during primary helminth infection, " The Journal of Immunology, vol. 186, no. 5, pp. 2719-2728, 2011.
207. H. Matsuda, H. Ushio, G. P. Geba, and P. W. Askenase, "Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies, " The Journal of Immunology, vol. 158, no. 6, pp. 2891-2897, 1997.
208. B. L. Fanburg and S.-L. Lee, "A new role for an old molecule: Serotonin as a mitogen, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 272, no. 5, part 1, pp. L795-L806, 1997.
209. M. Symons andN. Rusk, "Control of vesicular traffickingbyRho GTPases, " Current Biology, vol. 13, no. 10, pp. R409-R418, 2003.
210. L. Pavn, G. Sandoval-Lpez, M. Eugenia Hernndez et al., "Th2 cytokine response in major depressive disorder patients before treatment, " Journal of Neuroimmunology, vol. 172, no. 1-2, pp. 156-165, 2006.
211. M. E. Hernndez, D. Mendieta, D. Martez-Fong et al., "Variations in circulating cytokine levels during 52 week course of treatment with SSRI formajor depressive disorder, " European Neuropsychopharmacology, vol. 18, no. 12, pp. 917-924, 2008.
212. M. E. Hernandez, D. Mendieta, M. Prez-Tapia et al., "Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder, " Clinical and Developmental Immunology, vol. 2013, Article ID 267871, 11 pages, 2013.
213. A. Gonzlez, F. Fazzino, M. Castillo, S. Mata, and L. Lima, "Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes inmajor depression patients, " NeuroImmunoModulation, vol. 14, no. 1, pp. 8-15, 2007.
214. M. E. Hernandez, D. Martinez-Fong, M. Perez-Tapia, I. Estrada-Garcia, S. Estrada-Parra, and L. Pavn, "Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder, " European Neuropsychopharmacology, vol. 20, no. 2, pp. 88-95, 2010.
215. L. R. Watkins, E. D. Milligan, and S. F. Maier, "Spinal cord glia: new players in pain, " Pain, vol. 93, no. 3, pp. 201-205, 2001.
216. B. Banic, S. Petersen-Felix, O. K. Andersen et al., "Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia, " Pain, vol. 107, no. 1-2, pp. 7-15, 2004.
217. L. A. Nielsen and K. G. Henriksson, "Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition, " Best Practice and Research: Clinical Rheumatology, vol. 21, no. 3, pp. 465-480, 2007.
218. R. Dubner and K. M. Hargreaves, "The neurobiology of pain and its modulation, " Clinical Journal of Pain, vol. 5, supplement 2, pp. S1-S6, 1989.
219. M. F. Seidel andW. Mller, "Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists, " Expert Opinion on Pharmacotherapy, vol. 12, no. 9, pp. 1381-1391, 2011.
220. F. Wolfe, I. J. Russell, G. Vipraio, K. Ross, and J. Anderson, "Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population, " Journal of Rheumatology, vol. 24, no. 3, pp. 555-559, 1997.
221. I. J. Russell, J. E. Michalek, G. A. Vipraio, E. M. Fletcher, M. A. Javors, and C. A. Bowden, "Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome, " Journal of Rheumatology, vol. 19, no. 1, pp. 104-109, 1992.
222. E. Houvenagel, G. Forzy, O. Leloire et al., "Cerebrospinal fluid monoamines in primary fibromyalgia, " Revue du Rhumatisme et des Maladies Osteó-Articulaires, vol. 57, no. 1, pp. 21-23, 1990.
223. L. S. C. Carvalho, H. Correa, G. C. Silva et al., "May genetic factors in fibromyalgia help to identify patients with differentially altered frequencies of immune cells" Clinical & Experimental Immunology, vol. 154, no. 3, pp. 346-352, 2008.
224. M. Spth, T. Stratz, G. Neeck et al., "Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia, " Scandinavian Journal of Rheumatology, vol. 33, no. 4, pp. 267-270, 2004.
225. L. M. Arnold, E. V. Hess, J. I. Hudson, J. A. Welge, S. E. Berno, and P. E. Keck Jr., "A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment ofwomenwith fibromyalgia, "TheAmerican Journal ofMedicine, vol. 112, no. 3, pp. 191-197, 2002.
226. S. Sidibe, F. Saal, A. Rhodes-Feuillette et al., "Effects of serotonin and melanin on in vitro HIV-1 infection, " Journal of Biological Regulators andHomeostaticAgents, vol. 10, no. 1, pp. 19-24, 1996.
227. W. Z. Ho, R. Cherukuri, and S. D. Douglas, "The macrophage and HIV-1, " Immunology Series, vol. 60, pp. 569-587, 1994.
228. H. Choe, "Chemokine receptors in HIV-1 and SIV infection, " Archives of Pharmacal Research, vol. 21, no. 6, pp. 634-639, 1998.
229. B. Manglier, G. J. Guillemin, P. Clayette et al., "Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1 receptors, " British Journal of Pharmacology, vol. 154, no. 1, pp. 174-182, 2008.
230. K. Yu, C.-L. Qiu, G.-B. Yang et al., "Alteration of serotonin transporter messenger RNA level in the peripheral blood mononuclear cells from simian/human immunodeficiency virus infected Chinese rhesus macaques (Macaca mulatta), " Brain, Behavior, and Immunity, vol. 24, no. 2, pp. 298-305, 2010.
231. A. L. Zignego, A. Cozzi, R. Carpenedo et al., "HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment, " Digestive and Liver Disease, vol. 39, supplement 1, pp. S107-S111, 2007.
232. O. T. Sims, C. C. Whalen, L. G. Nackerud, and B. E. Bride, "Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis c viral logs during antiviral therapy, " Journal of Clinical Psychopharmacology, vol. 34, no. 1, pp. 80-84, 2014.
233. J. L. Munoz-Bellido, S. Munoz-Criado, and J. A. Garcà-Rodrguez, "Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors, " International Journal of Antimicrobial Agents, vol. 14, no. 3, pp. 177-180, 2000.
234. S. A. Stanley, A. K. Barczak, M. R. Silvis et al., "Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth, " PLoS Pathogens, vol. 10, no. 2, Article ID e1003946, 2014.
235. C. Lass-Flrl, M. P. Dierich, D. Fuchs, E. Semenitz, I. Jenewein, and M. Ledochowski, "Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro, " Journal of Antimicrobial Chemotherapy, vol. 48, no. 6, pp. 775-779, 2001.
236. N. Patocka and P. Ribeiro, "The functional role of a serotonin transporter in Schistosoma mansoni elucidated through immunolocalization and RNA interference (RNAi), " Molecular and Biochemical Parasitology, vol. 187, no. 1, pp. 32-42, 2013.
237. C. Lass-Flrl, D. Fuchs, M. Ledochowski, C. Speth, M. P. Dierich, and R. Wrzner, "Antifungal properties of 5-hydroxytryptamine (serotonin) against Candida species in vitro, " Journal of Medical Microbiology, vol. 52, no. 2, pp. 169-171, 2003.
238. B. Zhai, C. Wu, L. Wang, M. S. Sachs, and X. Lin, "The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections, " Antimicrobial Agents and Chemotherapy, vol. 56, no. 7, pp. 3758-3766, 2012.
239. Alzheimer's Association, "2012 Alzheimer's disease facts and figures, " Alzheimer's & Dementia, vol. 8, no. 2, pp. 131-168, 2012.
240. J. Hardy and D. J. Selkoe, "The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, " Science, vol. 297, no. 5580, pp. 353-356, 2002.
241. E. C. Hersch and S. Falzgraf, "Management of the behavioral and psychological symptoms of dementia, " Clinical Interventions in Aging, vol. 2, no. 4, pp. 611-621, 2007.
242. S. I. Garssadi, Y. Mandi, K. Regely, B. Tarodi, and I. Beladi, "The inhibitory effect of interferon-alpha on the serotonin-induced impairment of human NK cell activity in whole blood, " Brain, Behavior, and Immunity, vol. 7, no. 2, pp. 164-175, 1993.
243. A. Palots, L. G. Pusks, K. Kitajka et al., "The effect of citalopram on gene expression profile of Alzheimer lymphocytes, " Neurochemical Research, vol. 29, no. 8, pp. 1563-1570, 2004.
244. I. Tesseur, A. A. Pimenova, A. C. Lo et al., "Chronic 5-HT4 receptor activation decreases A production and deposition in hAPP/PS1 mice, " Neurobiology of Aging, vol. 34, no. 7, pp. 1779-1789, 2013.
245. S. Kopp and P. Alstergren, "Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis, " Mediators of Inflammation, vol. 11, no. 4, pp. 211-217, 2002.
246. W. Mller, B. L. Fiebich, and T. Stratz, "5-HT3 receptor antagonist als analgetics in rheumatic diseases, " Zeitschrift für Rheumatologie, vol. 65, no. 6, pp. 546-552, 2006.
247. S. Sacre, M. Medghalchi, B. Gregory, F. Brennan, and R. Williams, "Fluoxetine and citalopramexhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors, " Arthritis & Rheumatism, vol. 62, no. 3, pp. 683-693, 2010.
248. A. Frobe, L. Cicin-Sain, G. Jones et al., "Plasma free serotonin as a marker for early detection of breast cancer recurrence, " Anticancer Research, vol. 34, no. 3, pp. 1167-1169, 2014.
249. B. Grygier, B. Arteta, M. Kubera et al., "Inhibitory effect of antidepressants on B16F10 melanoma tumor growth, " Pharmacological Reports, vol. 65, no. 3, pp. 672-681, 2013.
250. A. Serafeim, M. J. Holder, G. Grafton et al., "Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells, " Blood, vol. 101, no. 8, pp. 3212-3219, 2003.
251. W. M. Oldham and H. E. Hamm, "Heterotrimeric G protein activation by G-protein-coupled receptors, " Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 60-71, 2008.
252. G. B. Downes and N. Gautam, "The G protein subunit gene families, " Genomics, vol. 62, no. 3, pp. 544-552, 1999.
253. C. E. Hagan, J. O. Schenk, and J. F. Neumaier, "The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes, " Synapse, vol. 65, no. 10, pp. 1015-1023, 2011.
254. N. L. Baganz andR. D. Blakely, "Adialogue between theimmune system and brain, spoken in the language of serotonin, " ACS Chemical Neuroscience, vol. 4, no. 1, pp. 48-63, 2013.